XML 61 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2

Stock-Based Compensation (Tables)

12 Months Ended

Oct. 01, 2022

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Schedule of Summary of Stock Options

			Shares Under Option						Weighted Average Exercise Price Per Share						Weighted Average Remaining Contractual Life (in Years)						Aggregate Intrinsic Value (in millions)
Outstanding, October 2, 2021			7,207,026						$	63.82
Exercised			(2,094,198)						61.16
Forfeited or expired			(539,743)						75.78
Granted			1,456,544						81.51
Outstanding, October 1, 2022			6,029,629						$	67.95					6.6						$	37
Exercisable, October 1, 2022			3,536,020						$	63.12					5.2						$	32

Schedule of Assumptions of Fair Value Calculation of Each Year's Grants

Assumptions used in the fair value calculation are as of the grant dates and are outlined in the following table.

			2022						2021						2020
Expected life (in years)			4.4						4.3						4.3
Risk-free interest rate			1.1		%				0.3		%				1.6		%
Expected volatility			30.0		%				32.2		%				25.7		%
Expected dividend yield			2.4		%				3.4		%				2.0		%

Schedule of Summary of Restricted Stock

			Number of Shares						Weighted Average Grant- Date Fair Value Per Share						Weighted Average Remaining Contractual Life (in Years)						Aggregate Intrinsic Value (in millions)
Nonvested, October 2, 2021			1,974,136						$	68.88
Granted			708,855						82.37
Dividends			12,833						82.51
Vested			(884,444)						64.92
Forfeited			(204,849)						74.87
Nonvested, October 1, 2022			1,606,531						$	76.36					1.4						$	106

Schedule of Summary of Performance-Based Shares

The following table summarizes the performance-based shares at the maximum award amounts based upon the respective performance share agreements. Actual shares that will vest depend on the level of attainment of the performance-based criteria.

			Number of Shares						Weighted Average Grant- Date Fair Value Per Share						Weighted Average Remaining Contractual Life (in Years)						Aggregate Intrinsic Value (in millions)
Nonvested, October 2, 2021			2,055,568						$	51.63
Granted			745,246						63.30
Vested			(395,310)						45.66
Forfeited			(623,985)						50.80
Nonvested, October 1, 2022			1,781,519						$	58.13					1.2						$	117

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration